Literature DB >> 15978558

Immunohistochemical study on the distribution of phosphorylated extracellular signal-regulated kinase (ERK) in the central nervous system of SOD1G93A transgenic mice.

Yoon Hee Chung1, Kyeung Min Joo, Heon Chang Lim, Mi Haeng Cho, Daejin Kim, Won Bok Lee, Choong Ik Cha.   

Abstract

In the present study, we performed immunohistochemical studies to investigate the changes of phosphorylated extracellular signal-regulated kinases (pERK) in the central nervous system of SOD1(G93A) transgenic mice. In symptomatic transgenic mice, pERK-immunoreactive astrocytes were detected in the spinal cord, brainstem, central gray and cerebellar nuclei. In contrast to symptomatic mice, no pERK-immunoreactive astrocytes were observed in any brain region of wtSOD1 and presymptomatic mice, and the number and intensity of stained neurons were not different at the age of 8 weeks and 13 weeks. Interestingly, region-specific alterations in pERK immunoreactivity were observed in the hippocampal region and cerebellum. These results provide the first evidence that pERK-immunoreactive astrocytes were found in the CNS of SOD1(G93A) transgenic mice after clinical symptoms, showing a possible consequence of the pathological process of ALS. This study has also demonstrated that pERK increases in the hippocampus and cerebellum, suggesting a role of pERK in an abnormality of cognitive and/or motor function in ALS, respectively. However, the mechanisms underlying the increased immunoreactivity for pERK and the functional implications require elucidation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978558     DOI: 10.1016/j.brainres.2005.05.060

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

2.  Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.

Authors:  María Moreno-Igoa; Ana Cristina Calvo; Clara Penas; Raquel Manzano; Sara Oliván; María Jesús Muñoz; Renzo Mancuso; Pilar Zaragoza; José Aguilera; Xavier Navarro; Rosario Osta Pinzolas
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

3.  Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.

Authors:  Petra Steinacker; Andreas Hawlik; Stefan Lehnert; Olaf Jahn; Stephen Meier; Evamaria Görz; Kerstin E Braunstein; Marija Krzovska; Birgit Schwalenstöcker; Sarah Jesse; Christian Pröpper; Tobias Böckers; Albert Ludolph; Markus Otto
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

Review 4.  Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases.

Authors:  Orjon Rroji; Amit Kumar; Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  Neurobiol Dis       Date:  2020-10-28       Impact factor: 5.996

5.  Mice with mutation in dynein heavy chain 1 do not share the same tau expression pattern with mice with SOD1-related motor neuron disease.

Authors:  Magdalena Kuźma-Kozakiewicz; Ewa Usarek; Albert C Ludolph; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2011-03-06       Impact factor: 3.996

6.  Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation.

Authors:  Gabriella Dobrowolny; Michela Aucello; Antonio Musarò
Journal:  Skelet Muscle       Date:  2011-01-24       Impact factor: 4.912

7.  Impact of treadmill running and sex on hippocampal neurogenesis in the mouse model of amyotrophic lateral sclerosis.

Authors:  Xiaoxing Ma; Mazen J Hamadeh; Brain R Christie; Jane A Foster; Mark A Tarnopolsky
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

8.  Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis.

Authors:  Nadine Bakkar; Tina Kovalik; Ileana Lorenzini; Scott Spangler; Alix Lacoste; Kyle Sponaugle; Philip Ferrante; Elenee Argentinis; Rita Sattler; Robert Bowser
Journal:  Acta Neuropathol       Date:  2017-11-13       Impact factor: 17.088

9.  Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway.

Authors:  Timothy G Lesnick; Eric J Sorenson; J Eric Ahlskog; John R Henley; Lina Shehadeh; Spiridon Papapetropoulos; Demetrius M Maraganore
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

Review 10.  Elusive roles for reactive astrocytes in neurodegenerative diseases.

Authors:  Lucile Ben Haim; Maria-Angeles Carrillo-de Sauvage; Kelly Ceyzériat; Carole Escartin
Journal:  Front Cell Neurosci       Date:  2015-08-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.